by Agilent Technologies
Polaris HPLC Columns
Performs Well Under Aqueous Conditions
In areas like drug discovery where target compounds are increasingly polar, it is critical to have a reversed-phase column that performs well under aqueous conditions. Retention is critical, but cannot come with troublesome secondary interactions. Likewise, phase collapse and shifting retention times need to be avoided. The answer is our Polaris line of polar modified columns.
| Vendor | Agilent Technologies | Pore size | 180 |
| Brand | Agilent Polaris | Surface Area | 200 |
| Modifification | Silica/C8 | Carbon Load, % | 7.4 |
| Mode | Reversed-Phase | Endcapped | Yes |
| Particle Size | Operating Temperature | 60 | |
| Length | pH stability to | 10.0 | |
| Internal Diameter |
| Vendor | Brand | Mode | Modification | Int. diam. | Length | Particles | Pores | Price |
|---|---|---|---|---|---|---|---|---|
| ACE | ACE C8 | Reversed-Phase | Silica/C8 | 21.2 mm | 250 mm | 5.0 μm | 100 Å | On request |
| Greyhound | GenSphere C8 120 | Reversed-Phase | Silica/C8 | 3.0 mm | 100 mm | 3.0 μm | 120 Å | On request |
| CHEMINDIA | CHEMSIL-OCTYL-C8 | Reversed-Phase | Silica/C8 | 3.9 mm | 75 mm | 3.0 μm | 100 Å | On request |
| ES Industries | Chromegabond 300 MC-8 | Reversed-Phase | Silica/C8 | 3.2 mm | 50 mm | 5.0 μm | 300 Å | On request |
| Aapptec | Spirit Protein | Reversed-Phase | Silica/C8 | 3.0 mm | 100 mm | 5.0 μm | 300 Å | On request |
| Orochem | Reliasil C8 90 | Reversed-Phase | Silica/C8 | 30.0 mm | 250 mm | 10.0 μm | 90 Å | On request |
| Welch Materials | Ultisil XB-C8 | Reversed-Phase | Silica/C8 | 2.1 mm | 33 mm | 3.0 μm | 120 Å | On request |
| GL Sciences | InertSustain C8 HP | Reversed-Phase | Silica/C8 | 4.6 mm | 100 mm | 3.0 μm | 100 Å | On request |
No customer reviews yet. Be the first to share your experience!
Reach thousands of researchers worldwide. Fill in your details and our team will contact you shortly.
